JP Patent

JP2005537285A — ラパマイシンヒドロキシエステルを含有する非経口製剤

Assigned to Wyeth LLC · Expires 2005-12-08 · 20y expired

What this patent protects

本発明は３−ヒドロキシ−２(ヒドロキシメチル)−２−メチル−プロピオン酸とのラパマイシン４２−エステル（ＣＣＩ−７７９）の非経口製剤を提供する。

USPTO Abstract

本発明は３−ヒドロキシ−２(ヒドロキシメチル)−２−メチル−プロピオン酸とのラパマイシン４２−エステル（ＣＣＩ−７７９）の非経口製剤を提供する。

Drugs covered by this patent

bendamustine-hydrochloride (BENDAMUSTINE HYDROCHLORIDE)

Patent Metadata

Patent number: JP2005537285A
Jurisdiction: JP
Classification: —
Expires: 2005-12-08
Drug substance claim: No
Drug product claim: No
Assignee: Wyeth LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.